×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

Indian manufacturer, Kenyan firm clash over Sh1.3b pharmaceutical deal

Prescription drugs. [Courtesy]

An Indian pharmaceutical manufacturer is locked in a dispute worth more than Sh1.3 billion with a Kenyan firm and the Pharmacy and Poisons Board (PPB), in a row over a distribution agreement.

Prism Life Sciences Limited has accused the Board of siding with Galaxy Pharmaceutical Limited by permitting it to supply products from multiple companies, while at the same time freezing the distribution of Prism’s medicines

Get Full Access for Ksh99/Week
Unlock the Full Story — Join Thousands of Informed Kenyans Today
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Access this article for Ksh5
Already a subscriber? Log in